A clinical trial in China aims to see if engineered immune cells can fight off late-stage lung cancer.
Funding for the NIH has had bipartisan support, but Trump has called the agency “terrible.”
Male contraception research is a field littered with failures, but a few promising candidates are in the pipeline.
A step toward repairing spinal cord injury with electronics.
A trial meant to control the spread of Zika virus in the U.S. could be delayed.
Synthetic biologists are developing genetically modified bacteria that you swallow, but no one knows yet how they should be regulated.
People and dogs share some cancer-causing genetic mutations. Now the government is funding an effort to learn from that.
A needleless, remote-controlled device for tissue expansion is awaiting FDA approval.
The billionaire is the first major donor to back the idea of creating an atlas of all human cells.
Nonprofits and corporations are in a race to fight dengue and Zika.